Testing effectiveness (Phase 2)Not Yet RecruitingNCT06748521What this trial is testingDynamic CtDNA-guided Targeted Therapy in DLBCLWho this might be right forDiffuse Large B Cell Lymphoma (DLBCL) Ruijin Hospital 108
Early research (Phase 1)Study completedNCT01897012What this trial is testingAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasWho this might be right forMYC PositiveRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Burkitt Lymphoma+14 more National Cancer Institute (NCI) 26
Early research (Phase 1)Looking for participantsNCT07308132What this trial is testingJNJ-95566692 in Participants With Non-Hodgkin Lymphoid MalignanciesWho this might be right forLymphoma, Non-Hodgkin Janssen Research & Development, LLC 340
Testing effectiveness (Phase 2)Ended earlyNCT00858793What this trial is testingHigh-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCTWho this might be right forAIDS-related LymphomaHIV Infections Universitätsklinikum Hamburg-Eppendorf 5
Not applicableStudy completedNCT05349201What this trial is testingCAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)Who this might be right forDiffuse Large B-Cell Lymphoma (DLBCL)Acute Lymphoblastic Leukemia (ALL) Novartis Pharmaceuticals 273
Not applicableEnded earlyNCT04982471What this trial is testingConnect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort StudyWho this might be right forLymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Follicular Celgene 36
Early research (Phase 1)Active Not RecruitingNCT04684563What this trial is testingHuCART19-IL18 in CD19+ CancersWho this might be right forChronic Lymphocytic LeukemiaNon-hodgkin LymphomaAcute Lymphoblastic Leukemia University of Pennsylvania 72
Not applicableStudy completedNCT00513175What this trial is testingNon-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more University of California, San Francisco 44
Testing effectiveness (Phase 2)Study completedNCT00709592What this trial is testingReduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCTWho this might be right forNon-Hodgkin's LymphomaLeukemiaMultiple Myeloma+5 more Virginia Commonwealth University 42
Early research (Phase 1)Study completedNCT03218072What this trial is testingEvaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell LymphomasWho this might be right forB-cell Lymphomas Shanghai Henlius Biotech 12
Early research (Phase 1)Ended earlyNCT03593109What this trial is testingA Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell LymphomaWho this might be right forLymphoma, B-Cell Second Affiliated Hospital of Xi'an Jiaotong University 1
Testing effectiveness (Phase 2)Study completedNCT02086175What this trial is testingClinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin LymphomaWho this might be right forRelapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas Dana-Farber Cancer Institute 25
Not applicableStudy completedNCT00049465What this trial is testingStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more Fred Hutchinson Cancer Center 150
Early research (Phase 1)Study completedNCT00724971What this trial is testingStudy Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And RituximabWho this might be right forLymphoma, B-Cell Pfizer 10
Early research (Phase 1)Study completedNCT00004101What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT02650999What this trial is testingPembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory LymphomasWho this might be right forCD19+ Diffuse Large B-cell LymphomasFollicular LymphomasMantle Cell Lymphomas Abramson Cancer Center at Penn Medicine 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571What this trial is testingThis is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Who this might be right forAcute Lymphobkastic LeukemiaB Cell Lymphoma Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300528What this trial is testingPemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomasWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin LymphomaMantle Cell LymphomaMarginal Zone Lymphoma University of Utah 1
Testing effectiveness (Phase 2)Looking for participantsNCT07499271What this trial is testingGenetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 MutationWho this might be right forDiffuse Large B-Cell Lymphoma (DLBCL) The First Affiliated Hospital of Soochow University 35